“Effective board service is a cornerstone of advancing innovation and strategic leadership in healthcare. Through collaborative governance and visionary oversight, we can drive scientific breakthroughs and transform patient outcomes.”
Dr. Knudsen’s dedication to excellence is exemplified through her active participation on multiple boards and advisory committees, spanning not-for-profit organizations, biotechnology firms, pharmaceutical companies, and esteemed cancer centers.
Not-for-Profit Organizations
• Research!America
• Director: 2023–Present
• Audit Committee Member: 2023–Present
• Association of American Cancer Institutes (AACI)
• Director: 2016–2021
• President & Chair: 2020–2021
• American Association for Cancer Research (AACR)
• Director: 2019–2021
• Chair, Nominating Committee: 2017–2018
• Campaign for Tobacco-Free Kids
• Director: 2021–2023
Biotechnology & Pharmaceutical Industry
• Exai Bio
• Director: 2024–Present
• Paradigm Health
• Director: 2024–Present
• Transcarent
• Board Advisor: 2024–Present
• ArteraAI
• Board Advisor: 2023–Present
• CellCentric
• Advisor: 2025–Present
• Genentech
• Scientific Review Board Member: 2019–Present
National Cancer Institute (NCI) Designated Cancer Centers
Dr. Knudsen lends her expertise to several NCI-designated cancer centers through their External Advisory Boards:
• MD Anderson Comprehensive Cancer Center
• Mayo Comprehensive Cancer Center
• Moffitt Comprehensive Cancer Center
• Northwestern Lurie Comprehensive Cancer Center
• UCSF Helen Diller Family Comprehensive Cancer Center
• University of Chicago Comprehensive Cancer Center
• University of Hawaii Cancer Center
• Vice Chair
• University of Minnesota Comprehensive Cancer Center
• University of New Mexico Comprehensive Cancer Center
• Chair